Global Resolution on Advancing Comprehensive Care and Health Equity for People with Bleeding Disorders Worldwide at the 79th WHA – WFH
World Federation of Hemophilia (WFH) shared a post on LinkedIn:
“Thank you to all policy-makers, Ministries’ of Health, Geneva Permanent Missions, WHO representatives, bleeding disorders advocates, expert clinicians, industry partners and international civil society actors who have joined us in Geneva for the 79th World Health Assembly Side Event: ‘Advancing Health Equity for Bleeding Disorders’, as well as many members of our global bleeding disorders community who joined from all over the world online.
Co-Hosted by the World Federation of Hemophilia (WFH), in collaboration with the Ministry of Health of the Republic of Armenia, Rare Diseases International, and the Swiss Haemophilia Society, and co-sponsored by the Ministries of Health and Population of Egypt, Nepal and SriLanka, this event offered inspiring opening addresses and two expert panel discussions, underlying the importance of the adoption of the WHA resolution on Global Action to Advance Health Activity for People with Bleeding Disorders Worldwide.
This Resolution is expected to be discussed at the 79th WHA this week, stay tuned for live updates from the WFH!”
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared this post on LinkedIn, adding:
“A meaningful step forward for global health equity.
Proud to see Armenia actively contributing to the international dialogue on bleeding disorders at WHA79 in Geneva.
Together with global partners, we continue advancing access, awareness, and care for people living with bleeding disorders worldwide.”
Stay updated with Hemostasis Today.
-
Jun 7, 2026, 05:50Sayan Koley: Lupus Anticoagulant – A Key Marker in Thrombosis Risk Assessment
-
Jun 7, 2026, 05:45Nicolas Hubacz: Watching a Heart Build Its Network
-
Jun 7, 2026, 05:40New Evidence Highlights the Urgent Need for Gender-Inclusive Bleeding Disorders Research – EHC
-
Jun 7, 2026, 03:15Shirley D’Sa: What Comes After BTK Inhibitors in Waldenström Macroglobulinaemia?
-
Jun 6, 2026, 23:30Yazan Abou-Ismail: Insights on A Snail-Derived Potential Anticoagulant with Possibly Improved Bleeding Profile
-
Jun 6, 2026, 18:40Igor Carvalho de Oliveira: The Hidden Genetic Risk Behind Early Heart Attacks and Strokes
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells